Trial intelligence / Profile preview

Bioequivalence of Cyproterone Acetate 50 mg vs ANDROCUR in Healthy Thai Volunteers (Fasting, Single-Dose Crossover)

TCTR20230226003Phase 1Unknown

Sponsor
Bio-innova
Start
May 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of cyproterone (2 arms), sponsored by Bio-innova. Status: unknown.

02

Drugs

cyproterone

Beyond the preview

Go deeper on TCTR20230226003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230226003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call